- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shilpa Medicare Limited — Updates, 03-06-2026: Press Release
03-06-2026 | 09:22 am
03-06-2026 | 09:22 am
Shilpa Biocare, a Shilpa Medicare subsidiary, acquired a 30.4% strategic equity stake in Gate2Brain for Euro 7 million. This partnership aims to advance G2B-002, a brain cancer therapy with Orphan Drug Designation, leveraging Shilpa's manufacturing and regulatory expertise for human trials.
No comments yet. Be the first to comment!